Drug Markets/Insulin Aspart

Insulin Aspart

11 NDCs across 1 manufacturer|5 Generic,6 Brand

▸ More about this market

In 2024, Medicare Part D spent $463 million on Insulin Aspart across 2.2 million claims for 750,000 beneficiaries.

Insulin Aspart is available as 11 NDCs from 1 manufacturer (5 generic, 6 brand), with NADAC prices from $6.93 to $8.96 per MLa 29% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

11

5G / 6B

Manufacturers

1

competing in market

Price Spread

$6.93 – $8.96

per ML

7d Activity

245 flat

avg -0.0% WoW · of 11 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing INSULIN ASPART

Frequently Asked Questions

How much does Medicare spend on Insulin Aspart?

In 2024, Medicare Part D spent $463 million on Insulin Aspart across 2.2 million claims for 750,000 beneficiaries.

How many Insulin Aspart products are on the market?

The Insulin Aspart drug market contains 11 NDCs from 1 manufacturer — 5 generic and 6 brand products.

What is the price range for Insulin Aspart?

NADAC reference prices for Insulin Aspart range from $6.9278 to $8.9607 per ML — a 29% difference between cheapest and most expensive.

Is generic Insulin Aspart cheaper than brand?

The average generic NADAC for Insulin Aspart is $8.0750 per ML, versus $8.1475 for brand-labeled products — generic is about 1% cheaper on average.

Which manufacturers make Insulin Aspart?

1 manufacturer lists Insulin Aspart in NADAC. Ranked by number of NDCs, the largest are Novo Nordisk (11).

How has the price of Insulin Aspart changed recently?

Over the past 7 days, 2 Insulin Aspart NDCs rose and 4 fell, with a market-wide average change of -0.0%.